Loading clinical trials...
Loading clinical trials...
The prevalence of non-alcoholic fatty liver disease (NAFLD ) in the American population is approximately 30% in adults and 10% in children, making it the most common. Cause of chronic liver disease in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Methodist Health System
NCT03151473 · Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH)
NCT02754037 · Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH)
NCT06168383 · Non-Alcoholic Steatohepatitis (NASH)
NCT05989711 · Non-Alcoholic Steatohepatitis (NASH)
NCT00666016 · Non-Alcoholic Steatohepatitis (NASH)
The Liver Institute at Methodist Dallas Medical Center
Irving, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions